Filing Flows › Lexicon Pharmaceuticals (LXRX) › How it makes money
How Lexicon Pharmaceuticals (LXRX) makes money
Lexicon Pharmaceuticals (LXRX) made $11.2M of revenue in the third quarter 2026 (Q3 2026), -21% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $11.2M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $11.2M | -21% |
| Q2 2026 | $692K | -98% |
| Q1 2026 | $21.1M | 17× |
| Q4 2025 | $5.5M | -79% |
| Q3 2025 | $14.2M | +710% |
| Q2 2025 | $28.9M | 18× |
| Q1 2025 | $1.3M | +12% |
From Lexicon Pharmaceuticals' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Lexicon Pharmaceuticals make money?
Lexicon Pharmaceuticals (LXRX) made $11.2M of revenue in the third quarter 2026 (Q3 2026), -21% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.